Standout Papers
- Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE) (2000)
- Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study (2012)
- Clinical review on triglycerides (2019)
- A Modern Approach to Dyslipidemia (2021)
- Olezarsen, Acute Pancreatitis, and Familial Chylomicronemia Syndrome (2024)
- Zodasiran, an RNAi Therapeutic Targeting ANGPTL3, for Mixed Hyperlipidemia (2024)
- Plozasiran for Managing Persistent Chylomicronemia and Pancreatitis Risk (2024)
Immediate Impact
5 by Nobel laureates 12 from Science/Nature 68 standout
Citing Papers
Plozasiran, an RNA Interference Agent Targeting APOC3, for Mixed Hyperlipidemia
2024 Standout
Olezarsen for Hypertriglyceridemia in Patients at High Cardiovascular Risk
2024 Standout
Works of Robert A. Hegele being referenced
Olezarsen, Acute Pancreatitis, and Familial Chylomicronemia Syndrome
2024 Standout
Genetic determinants of plasma triglycerides
2010
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Robert A. Hegele | 9954 | 7761 | 7567 | 719 | 25.9k | |
| Christian Ehnholm | 9150 | 4472 | 5270 | 375 | 21.3k | |
| Jan L. Breslow | 11853 | 4868 | 9575 | 266 | 29.5k | |
| Gerd Assmann | 11925 | 4913 | 7574 | 452 | 25.5k | |
| Erik S.G. Stroes | 13344 | 7919 | 4909 | 490 | 28.5k | |
| Steve E. Humphries | 13992 | 9743 | 7824 | 860 | 41.5k | |
| Ira J. Goldberg | 5751 | 7759 | 8912 | 330 | 25.2k | |
| Ernst J. Schaefer | 15774 | 6339 | 5034 | 377 | 34.6k | |
| Anders Hamsten | 6327 | 7767 | 5650 | 386 | 29.7k | |
| Anne Tybjærg‐Hansen | 10644 | 7161 | 4977 | 341 | 27.4k | |
| Arnold von Eckardstein | 7909 | 3919 | 6400 | 417 | 21.8k |
All Works
Login with ORCID to disown or claim papers
Loading papers...